biotech en Biotech sector wants help from Albany <p>Although New York&#39;s legislative session wrapped up in June, angling for new public policy hasn&#39;t ceased.</p><div class="card-content"><div class="field field-name-body field-type-text-with-summary field-label-hidden "><div class="field-items"><div class="field-item even"><p>Recently, the Business Council of New York State (BCNYS) tried to <a href="" target="_blank">regain traction for its agenda</a> by re-releasing a <a href="" target="_blank">report from May</a>.</p><p> Thu, 05 Jul 2012 12:50:43 +0000 Daniel Robison 22065 at The case for investing in research <p>Investments in research take a while to pay dividends.</p><p>So says Dr. Karin Pavese, director of innovation at the New York Academy of Sciences.</p><p>At a <a href="" target="_blank">biotechnology symposium</a> in Syracuse Tuesday, Pavese told attendees there&#39;s great growth potential in state-backed research. But since the fruits of those investments often take many years to bloom, Pavese&nbsp;says politicians are often hesitant to pony up key funding.</p><p>One job created in the innovation work force - like a research position - creates three additional jobs, according to Pavese.</p><p>But standing in the way is something called the &quot;valley of death.&quot;</p><p> Wed, 23 May 2012 15:20:14 +0000 Ryan Delaney 19739 at The case for investing in research